You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ALFUZOSIN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Alfuzosin Hydrochloride, and when can generic versions of Alfuzosin Hydrochloride launch?

Alfuzosin Hydrochloride is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Norvium Bioscience, Sun Pharm, Torrent Pharms, Unichem, and Wockhardt. and is included in nine NDAs.

The generic ingredient in ALFUZOSIN HYDROCHLORIDE is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alfuzosin Hydrochloride

A generic version of ALFUZOSIN HYDROCHLORIDE was approved as alfuzosin hydrochloride by APOTEX INC on July 18th, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALFUZOSIN HYDROCHLORIDE?
  • What are the global sales for ALFUZOSIN HYDROCHLORIDE?
  • What is Average Wholesale Price for ALFUZOSIN HYDROCHLORIDE?
Drug patent expirations by year for ALFUZOSIN HYDROCHLORIDE
Recent Clinical Trials for ALFUZOSIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beth Israel Deaconess Medical CenterN/A
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A
Gundersen Lutheran Medical FoundationPhase 4

See all ALFUZOSIN HYDROCHLORIDE clinical trials

Pharmacology for ALFUZOSIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for ALFUZOSIN HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
UROXATRAL Extended-release Tablets alfuzosin hydrochloride 10 mg 021287 9 2007-06-12

US Patents and Regulatory Information for ALFUZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079013-001 Jul 18, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079054-001 Jul 18, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Invagen Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 090284-001 Jan 17, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Unichem ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 203192-001 Jan 28, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.